Nationally-Renowned Scholar Henry Miller, M.S., M.D., Joins Pacific Research Institute as Senior Fellow in Health Care – Pacific Research Institute

Nationally-Renowned Scholar Henry Miller, M.S., M.D., Joins Pacific Research Institute as Senior Fellow in Health Care

Former Hoover Fellow’s Research Will Focus on Genetic Engineering, Evidence-Based Medicine, Regulatory Reform

SAN FRANCISCO – The Pacific Research Institute, California’s leading free-market think tank, today announced the hiring of nationally-renowned scholar and researcher and former Hoover Institution fellow Dr. Henry Miller as a Senior Fellow in Health Care.  At PRI, Miller will continue his research and writing on a broad spectrum of scientific and medical issues, including genetic engineering, the development of prescription drugs, precision medicine, junk science, and regulatory reform.

“Sally Pipes and PRI are leading the way in fighting government health care initiatives and advocating for regulatory relief to encourage the development of new, life-saving cures,” said Miller.  “I’m pleased to join PRI in furthering their mission of advancing free-market health care reforms and evidence-based public policy and welcome the opportunity to continue my research on cutting-edge health care issues.”

“Dr. Henry Miller has conducted vital research over the years on complex issues like genetic engineering and emerging viral diseases,” said PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, Sally C. Pipes.  “We are so fortunate that Dr. Miller has joined PRI’s team, and look forward to his work educating the public and policymakers on the need to get government out of the way to encourage the next innovations in health care, agriculture, and environmental protection.”

Dr. Miller was educated at M.I.T. (B.S.) and the University of California, San Diego (M.S., M.D.) and was a Clinical Fellow in Medicine at Harvard Medical School and a Research Fellow at the National Institutes of Health.  As a laboratory scientist, he was the co-discoverer of a critical enzyme in the influenza virus.  As a medical officer at the Food & Drug Administration, where he served for 15 years, Dr. Miller was the medical reviewer and head of the team that reviewed and approved the first biopharmaceutical, human insulin.

Immediately prior to joining PRI, Miller served as the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution.  During his time at Hoover, his research and commentaries were published regularly in scholarly journals and media publications, and he was a regular guest on the nationally-syndicated John Batchelor and Lars Larson radio programs.

Among his notable books are Policy Controversy in Biotechnology: An Insider’s View; To America’s Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth:  How Protest and Politics Threaten the Biotech Revolution, which Barron’s selected as one of the 25 Best Books of 2004.

His most recent research has centered around the need for evidence-based regulation that imposes the minimum burden on regulated industries and individuals, increasing freedom and allowing market forces to function.

The Pacific Research Institute ( champions freedom, opportunity, and personal responsibility by advancing free-market policy ideas.  Follow PRI on Facebook, Twitter, and LinkedIn.


Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top